Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
High level of vaccine efficacy maintained over a 6-month period of surveillance
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022
Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Collaboration with MTPC to discover novel hit compounds for multiple drug targets
Subscribe To Our Newsletter & Stay Updated